We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SANA market cap is 538.37M. The company's latest EPS is USD -1.2733 and P/E is -1.90.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -116.29M | -2.18M | -90.62M | -110.72M | -49.37M |
| Net Income | -114M | 984k | -88.12M | -107.48M | -50.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -141.15M | -286.15M | -367.98M | -272.56M | -293.14M |
| Net Income | -130.78M | -285.31M | -367M | -269.48M | -283.26M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 707.15M | 631.44M | 565.3M | 681.38M | 618.67M |
| Total Liabilities | 352.12M | 265.59M | 277.79M | 306.24M | 279.02M |
| Total Equity | 355.03M | 365.85M | 287.51M | 375.14M | 339.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 415.7M | 730.3M | 1.13B | 822.72M | 565.3M |
| Total Liabilities | 140.88M | 298.58M | 400.91M | 323.41M | 277.79M |
| Total Equity | -142.54M | -421.18M | 728.5M | 499.32M | 287.51M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -138.07M | -201.62M | -253.58M | -65.63M | -124.17M |
| Investing | 105.35M | 156.7M | 172.01M | -77.23M | -71.41M |
| Financing | 29.74M | 29.93M | 31.65M | 186.4M | 197.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -85.5M | -137.98M | -251.05M | -290.05M | -253.58M |
| Investing | -87.86M | -252.56M | -245.8M | 210.56M | 172.01M |
| Financing | 223.73M | 435.69M | 631.75M | 4.91M | 31.65M |
| Market Cap | 538.37M |
| Price to Earnings Ratio | -1.90 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.03 |
| Price to Book Ratio | 1.87 |
| Dividend Yield | - |
| Shares Outstanding | 222.47M |
| Average Volume (1 week) | 2.04M |
| Average Volume (1 Month) | 1.52M |
| 52 Week Change | -43.46% |
| 52 Week High | 12.00 |
| 52 Week Low | 2.345 |
| Spread (Intraday) | 0.17 (6.67%) |
| Company Name | Sana Biotechnology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sana.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
